March 3, 2026Open Access

Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer

Key Points

The analysis reveals significant variation in antiemetic effectiveness across different CINV phases, impacting patients' experiences.
Data from a homogeneous cohort underscores the need for tailored prophylactic strategies for symptom management.
Assessment of real-world evidence highlights a crucial connection between antiemetic use and quality of life during chemotherapy.
Optimizing strategies for nausea control may enhance overall patient well-being, indicating a need for further phase-specific guidelines.

Abstract

This real-world analysis demonstrates that antiemetic effectiveness varies by CINV phase, even within a relatively homogeneous, high-risk patient cohort. The results highlight the importance of phase-tailored prophylactic strategies to optimize symptom control and improve patient quality of life in highly emetogenic chemotherapy settings.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Akif Doğan

Hande Nur Erölmez

Goncagül Akdağ

Journals

Current Oncology

SHILAP Revista de lepidopterología

Actions

Institutions

Sağlık Bilimleri Üniversitesi

Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi

University of Health Sciences Antigua

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study